Immediate Impact
16 standout
Citing Papers
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
2025 Standout
Works of Narges Jokar being referenced
PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach
2023
Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Narges Jokar | 120 | 153 | 52 | 72 | 21 | 253 | |
| Ghasemali Divband | 147 | 201 | 66 | 85 | 30 | 281 | |
| Hong Grafe | 118 | 165 | 21 | 102 | 17 | 253 | |
| Miriam Sraieb | 125 | 96 | 55 | 45 | 15 | 217 | |
| Xin Zhou | 138 | 218 | 41 | 47 | 26 | 298 | |
| Jieyu Yu | 182 | 174 | 53 | 53 | 25 | 294 | |
| F. Penault Llorca | 49 | 160 | 38 | 54 | 14 | 270 | |
| Fiona E. Scott | 56 | 101 | 32 | 22 | 19 | 204 | |
| Márcio Debiasi | 43 | 110 | 138 | 38 | 22 | 281 | |
| Reyhaneh Manafi‐Farid | 186 | 112 | 160 | 36 | 24 | 307 | |
| Hanxiang Liu | 111 | 204 | 75 | 85 | 22 | 302 |
All Works
Login with ORCID to disown or claim papers
Loading papers...